These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3321494

  • 1. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
    Rudofsky G, Haussler KF, Künkel HP, Schneider-May H, Spengel F, Symann O, Werner HJ, Rössner M.
    Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
    Tonak J, Knecht H, Groitl H.
    Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
    [No Abstract] [Full Text] [Related]

  • 3. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Dtsch Med Wochenschr; 1987 May 29; 112(22):873-8. PubMed ID: 3556133
    [Abstract] [Full Text] [Related]

  • 4. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Vasa Suppl; 1987 May 29; 20():384-7. PubMed ID: 3321495
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G, Haussler KF, Künkel HP, Schneider-May H, Spengel F, Symann O, Werner HJ.
    Angiology; 1989 Jul 29; 40(7):639-49. PubMed ID: 2662830
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D.
    Med Welt; 1978 Aug 11; 29(32):1244-7. PubMed ID: 672594
    [No Abstract] [Full Text] [Related]

  • 7. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    J Med; 1988 Aug 11; 19(2):89-107. PubMed ID: 3049876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G, von Bary S, Breddin K, Diehm C, Gruss JD, Heinrich H, Horsch S, Kriessmann A, Maass U, Martin M.
    Vasa Suppl; 1989 Aug 11; 28():44-9. PubMed ID: 2692200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W, von Bary S, Corovic D, Diehm C, Mühe E, Rudofsky G, Scheffler P, Trübestein G, Vogelpohl M.
    Vasa Suppl; 1991 Aug 11; 33():348-9. PubMed ID: 1788753
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
    Ganança MM, Mangabeira Albernaz PL, Caovilla HH, Ito YI.
    Pharmatherapeutica; 1988 Aug 11; 5(3):170-6. PubMed ID: 3283777
    [Abstract] [Full Text] [Related]

  • 15. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
    Accetto B.
    Am Heart J; 1982 May 11; 103(5):864-9. PubMed ID: 7041579
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT, Strandness DE.
    Am Heart J; 1982 Jul 11; 104(1):66-72. PubMed ID: 7046409
    [Abstract] [Full Text] [Related]

  • 17. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F, Rotatori P, Frausini G.
    Ric Clin Lab; 1981 Jul 11; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract] [Full Text] [Related]

  • 18. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH, Kaul DK, Connel MM, Fabry ME, Nagel RL.
    Nouv Rev Fr Hematol (1978); 1989 Jul 11; 31(6):403-7. PubMed ID: 2694097
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT, Quinton DN, Barrie WW.
    N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.